![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 8, 4642-4646, February 20, 1998
From the Department of Pathology, Anatomy and Cell Biology and the
Perlecan, a heparan sulfate proteoglycan of
basement membranes and cell surfaces, has been implicated in the
control of tumor cell growth and metastasis because of its ability to
bind and store growth factors and its activity as an inducer of
angiogenesis. Because interferon-
Kimmel Cancer Center, Jefferson Medical College, Thomas
Jefferson University, Philadelphia, Pennsylvania 19107
(IFN-
), a cytokine with known
antiproliferative and antitumoral activity, binds with high affinity to
the heparan sulfate side chains of perlecan, we investigated the
activity of IFN-
on perlecan gene expression and cell growth in
colon carcinoma cells. We found that IFN-
rapidly and efficiently
blocked perlecan gene expression with concurrent growth
suppression, a phenomenon that was independent of a functional
p21WAF1/CIP1. These effects were transcriptionally mediated,
did not require new protein synthesis, and were fully reversible.
Moreover, we found these IFN-
-induced effects to be generalizable
because they could be reproduced in a variety of cells with various
histogenetic backgrounds. The transcriptional repression of the
perlecan gene required intact Stat1 protein, and these effects were
likely mediated by Stat1-binding sites in the distal promoter region.
Thus, the IFN-
-mediated transcriptional repression of perlecan may
represent a novel antitumoral effect of this cytokine through which it
eliminates a powerful angiogenic stimulus.
This article has been cited by other articles:
![]() |
X. Liu, L. Ye, Y. Bai, H. Mojidi, N. E. Simister, and X. Zhu Activation of the JAK/STAT-1 Signaling Pathway by IFN-{gamma} Can Down-Regulate Functional Expression of the MHC Class I-Related Neonatal Fc Receptor for IgG J. Immunol., July 1, 2008; 181(1): 449 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hallermalm, K. Seki, A. De Geer, B. Motyka, R. C. Bleackley, M. J. Jager, C. J. Froelich, R. Kiessling, V. Levitsky, and J. Levitskaya Modulation of the Tumor Cell Phenotype by IFN-{gamma} Results in Resistance of Uveal Melanoma Cells to Granule-Mediated Lysis by Cytotoxic Lymphocytes J. Immunol., March 15, 2008; 180(6): 3766 - 3774. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C Farach-Carson and D. D Carson Perlecan a multifunctional extracellular proteoglycan scaffold Glycobiology, September 1, 2007; 17(9): 897 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ma, H. Qin, and E. N. Benveniste Transcriptional Suppression of Matrix Metalloproteinase-9 Gene Expression by IFN-{gamma} and IFN-{beta}: Critical Role of STAT-1{alpha} J. Immunol., November 1, 2001; 167(9): 5150 - 5159. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-S. Zhu and J. P.-Y. Ting A 36-Amino-Acid Region of CIITA Is an Effective Inhibitor of CBP: Novel Mechanism of Gamma Interferon-Mediated Suppression of Collagen {alpha}2(I) and Other Promoters Mol. Cell. Biol., October 15, 2001; 21(20): 7078 - 7088. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Stewart, G. A. Johnson, C. A. Vyhlidal, R. C. Burghardt, S. H. Safe, L.-Y. Yu-Lee, F. W. Bazer, and T. E. Spencer Interferon-{{tau}} Activates Multiple Signal Transducer and Activator of Transcription Proteins and Has Complex Effects on Interferon-Responsive Gene Transcription in Ovine Endometrial Epithelial Cells Endocrinology, January 1, 2001; 142(1): 98 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Valles, C. Tsoi, W.-Y. Huang, D. Wyllie, F. Carlotti, J. A. Askari, M. J. Humphries, S. K. Dower, and E. E. Qwarnstrom Recruitment of a Heparan Sulfate Subunit to the Interleukin-1 Receptor Complex. REGULATION BY FIBRONECTIN ATTACHMENT J. Biol. Chem., July 16, 1999; 274(29): 20103 - 20109. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Ghosh, W. Yuan, Y. Mori, S.-j. Chen, and J. Varga Antagonistic Regulation of Type I Collagen Gene Expression by Interferon-gamma and Transforming Growth Factor-beta . INTEGRATION AT THE LEVEL OF p300/CBP TRANSCRIPTIONAL COACTIVATORS J. Biol. Chem., March 30, 2001; 276(14): 11041 - 11048. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. V. Fuki, R. V. Iozzo, and K. J. Williams Perlecan Heparan Sulfate Proteoglycan. A NOVEL RECEPTOR THAT MEDIATES A DISTINCT PATHWAY FOR LIGAND CATABOLISM J. Biol. Chem., August 11, 2000; 275(33): 25742 - 25750. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |